 |
 |
|
|
RESÚMENES MARZO 2005 |
Addictive Disorders
(Requiere
estar conectado a internet. Haga un click en la información del journal)
Elevated
levels of endocannabinoids and CB1 receptor-mediated G-protein
signaling in the prefrontal cortex of alcoholic suicide victims
K. Yaragudri Vinod,
Victoria Arango, Shan Xie, Suham A. Kassir, J. John Mann, Thomas B. Cooper and
Basalingappa L. Hungund
Biological Psychiatry. Volume 57, Issue 5, 1 March 2005, Pages
480-486
Effect of benzodiazepines on the metabolism of buprenorphine in human
liver microsomes
Yan Chang and
David E. Moody
European Journal of Clinical Pharmacology 2005; Volume
60, Number 12: 875 - 881
Unmanageable
Motivation in Addiction: A Pathology in Prefrontal-Accumbens Glutamate
Transmission
P.W. Kalivas, N.
Volkow and J. Seamans
Neuron.
Volume 45, Issue 5, 3 March 2005, Pages 647-650
Jeffery N. Wilkins
Psychiatric Times February 2005; Vol. XXII, Issue 2
Smoking and the Risk of Suicidal Behavior. A Prospective
Study of a Community Sample
Naomi
Breslau, Lonni R. Schultz, Eric O. Johnson, Edward L. Peterson, Glenn C. Davis
Arch Gen Psychiatry. 2005;62:328-334
Desipramine
Treatment for Cocaine Dependence in Buprenorphine- or Methadone-treated
Patients: Baseline Urine Results as Predictor of Response
Thomas Kosten, Mehmet
Sofuoglu, James Poling, Kishor Gonsai, Alison Oliveto
American Journal on Addictions. Volume 14, Number 1 / January–February: 8 - 17
Lack of Hippocampal Volume Change in Long-term
Heavy Cannabis Users
Golfo K. Tzilos, Christina
B. Cintron, Jonas B.R. Wood, Norah S. Simpson, Ashley D. Young, Harrison G. Pope,
Deborah A. Yurgelun-Todd
American Journal on Addictions. Volume 14, Number 1 /
January–February: 64 - 72
DSM-IV
Diagnostic Criteria for Pathological Gambling: Reliability, Validity, and
Classification Accuracy
Randy Stinchfield, Richard
Govoni, G. Ron Frisch
American Journal on Addictions. Volume 14, Number 1 /
January–February: 73 - 82
Martina Reynolds,
Gillian Mezey, Murray Chapman, Mike Wheeler, Colin Drummond and Alex
Baldacchino
Drug and Alcohol Dependence. Volume 77, Issue 3, 7
March 2005, Pages 251-258
Steven Belenko and
Jordon Peugh
Drug and Alcohol Dependence. Volume 77, Issue 3, 7
March 2005, Pages 269-281
Saul Shiffman
Drug and Alcohol Dependence. Volume 77, Issue 3, 7
March 2005, Pages 311-314
Efficacy
of antidepressants in substance use disorders with and without comorbid
depression. A systematic review and meta-analysis
Marta Torrens,
Francina Fonseca, Gerard Mateu and Magí Farré
Drug and Alcohol Dependence. Volume 78, Issue 1, 4
April 2005, Pages 1-22
High prevalence of
substance use disorders among adolescents who use marijuana and inhalants
Li-Tzy Wu, Daniel
J. Pilowsky and William E. Schlenger
Drug and Alcohol Dependence. Volume 78, Issue 1, 4
April 2005, Pages 23-32
Randomized
controlled study transitioning opioid-dependent pregnant women from
short-acting morphine to buprenorphine or methadone
Hendree E. Jones,
Rolley E. Johnson, Donald R. Jasinski and Lorraine Milio
Drug and Alcohol Dependence. Volume 78, Issue 1, 4
April 2005, Pages 33-38
Conceptual framework for the etiology of alcoholism: a “kindling”/stress
hypothesis
George R. Breese,
David H. Overstreet and Darin J. Knapp
Psychopharmacology 2005; Volume 178, Number
4: 367 - 380
Substance use
disorder comorbidity in major depressive disorder: an exploratory analysis of
the Sequenced Treatment Alternatives to Relieve Depression cohort
Lori L. Davis, John
A. Rush, Stephen R. Wisniewski, Kayla Rice, Paolo Cassano, Michele E. Jewell,
Melanie M. Biggs, Kathy Shores-Wilson, G.K. Balasubramani, Mustafa M. Husain,
Frederic M. Quitkin and Patrick J. McGrath
Comprehensive Psychiatry. Volume 46, Issue 2,
March-April 2005, Pages 81-89
Effects
of haloperidol on reactions to smoking cues in humans
Mahler SV, de Wit H
Behav Pharmacol. 2005 Mar;16(2):123-6
Karen
B. Domino; Thomas F. Hornbein; Nayak L. Polissar; Ginger Renner; Jilda Johnson;
Scott Alberti; Lynn Hankes
N Hiroi and S
Agatsuma